Trileptal Related Published Studies
Well-designed clinical trials related to Trileptal (Oxcarbazepine)
Oxcarbazepine for neuropathic pain. [2013]
Pharmacokinetics of the monohydroxy derivative of oxcarbazepine and its enantiomers after a single intravenous dose given as racemate compared with a single oral dose of oxcarbazepine. [2011.06]
Effect of eslicarbazepine acetate and oxcarbazepine on cognition and psychomotor function in healthy volunteers. [2010.08]
[Efficacy and safety of the monotherapy with trileptal (oxcarbazepine) in children and adolescents.] [2010]
Comparative efficacy and safety of oxcarbazepine versus divalproex sodium in the treatment of acute mania: a pilot study. [2009.04]
Effect of Oxcarbazepine in the Treatment of Agitation and Aggression in Severe Dementia. [2009.02.02]
Bipolar I and II disorder residual symptoms: Oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial. [2009.02.01]
Effect of oxcarbazepine in the treatment of agitation and aggression in severe dementia. [2009]
Bioequivalence of oxcarbazepine oral suspension vs. film-coated tablet in healthy Chinese male subjects. [2008.10]
A double-blind, randomized, placebo-controlled prophylaxis trial of oxcarbazepine as adjunctive treatment to lithium in the long-term treatment of bipolar I and II disorder. [2008.06]
A double-blind, randomized, placebo-controlled prophylaxis trial of oxcarbazepine as adjunctive treatment to lithium in the long-term treatment of bipolar I and II disorder. [2008.03.17]
Oxcarbazepine in migraine headache: a double-blind, randomized, placebo-controlled study. [2008.02.12]
Parent drug and/or metabolite? Which of them is most appropriate to establish bioequivalence of two oral oxcarbazepine formulations in healthy volunteers? [2007.07]
Oxcarbazepine--efficacy and tolerability during treatment of alcohol withdrawal: a double-blind, randomized, placebo-controlled multicenter pilot study. [2007.07]
The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. [2007.03.24]
Diagnostics for confounding in PK/PD models for oxcarbazepine. [2007.01.30]
Efficacy of oxcarbazepine for prophylaxis against cumulative oxaliplatin-induced neuropathy. [2006.12.26]
A pilot clinical trial of oxcarbazepine in adults with attention-deficit hyperactivity disorder. [2006.08.30]
Effects of oxcarbazepine on cognitive function in children and adolescents with partial seizures. [2006.08.22]
A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents. [2006.07]
Oxcarbazepine in painful diabetic neuropathy: results of a dose-ranging study. [2006.06]
Oxcarbazepine versus phenytoin monotherapy for epilepsy. [2006.04.19]
Diagnostics for confounding in PK/PD models for oxcarbazepine. [2006.04.13]
A pilot study of oxcarbazepine versus acamprosate in alcohol-dependent patients. [2006.04]
Oxcarbazepine in patients with impulsive aggression: a double-blind, placebo-controlled trial. [2005.12]
Lack of pharmacokinetic interaction between oxcarbazepine and lamotrigine. [2005.12]
Oxcarbazepine as add-on therapy in Thai epileptic patients with refractory partial seizures. [2005.11]
Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study. [2005.10]
Effects of oxcarbazepine and phenytoin on the EEG and cognition in healthy volunteers. [2004.12]
Oxcarbazepine pharmacokinetics and tolerability in children with inadequately controlled epilepsy. [2004.11]
Clinical, cognitive, and neurophysiologic correlates of short-term treatment with carbamazepine, oxcarbazepine, and levetiracetam in healthy volunteers. [2004.11]
Immediate (overnight) switching from carbamazepine to oxcarbazepine monotherapy is equivalent to a progressive switch. [2004.06]
Efficacy of oxcarbazepine in the treatment of painful diabetic neuropathy. [2004.05]
Sustained efficacy and long-term safety of oxcarbazepine: one-year open-label extension of a study in refractory partial epilepsy. [2003.09]
Pharmacokinetic drug interactions in children taking oxcarbazepine. [2003.08]
Assessment of the bioequivalence of two oxcarbazepine oral suspensions versus a film-coated tablet in healthy subjects. [2003.07]
Safety and tolerability of oxcarbazepine in elderly patients with epilepsy. [2003.04]
Oxcarbazepine final market image tablet formulation bioequivalence study after single administration and at steady state in healthy subjects. [2002.11]
Oxcarbazepine (Trileptal) as monotherapy in patients with partial seizures. [2001.09.11]
Oxcarbazepine, an antiepileptic agent. [2001.05]
Oxcarbazepine placebo-controlled, dose-ranging trial in refractory partial epilepsy. [2000.12]
Oxcarbazepine monotherapy for partial-onset seizures: a multicenter, double-blind, clinical trial. [2000.06.27]
Adjunctive therapy with oxcarbazepine in children with partial seizures. The Oxcarbazepine Pediatric Study Group. [2000.06.27]
Induction of ethinylestradiol and levonorgestrel metabolism by oxcarbazepine in healthy women. [1999.06]
Oxcarbazepine: double-blind, randomized, placebo-control, monotherapy trial for partial seizures. [1999.03.10]
A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy. [1997.06]
A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy. [1997.06]
A double-blind controlled clinical trial: oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy. [1997.03]
Effects of felbamate on the pharmacokinetics of the monohydroxy and dihydroxy metabolites of oxcarbazepine. [1995.10]
The influence of food on the disposition of the antiepileptic oxcarbazepine and its major metabolites in healthy volunteers. [1994.08]
Effects of the antidepressant drug viloxazine on oxcarbazepine and its hydroxylated metabolites in patients with epilepsy. [1994.08]
A double-blind, placebo-controlled interaction study between oxcarbazepine and carbamazepine, sodium valproate and phenytoin in epileptic patients. [1994.01]
The pharmacokinetics of oxcarbazepine and its active metabolite 10-hydroxy-carbazepine in healthy subjects and in epileptic patients treated with phenobarbitone or valproic acid. [1993.10]
Absence of interaction between oxcarbazepine and erythromycin. [1992.08]
Effects of oxcarbazepine and carbamazepine on the central nervous system: computerised analysis of saccadic and smooth-pursuit eye movements. [1992.06]
Cognitive effects of oxcarbazepine and phenytoin monotherapy in newly diagnosed epilepsy: one year follow-up. [1992.05]
Oxcarbazepine does not interact with cimetidine in healthy volunteers. [1992.04]
A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy. [1989.01]
Oxcarbazepine (GP 47.680): a possible alternative to carbamazepine? [1987.11]
Well-designed clinical trials possibly related to Trileptal (Oxcarbazepine)
Novel design for a phase IIa placebo-controlled, double-blind randomized
withdrawal study to evaluate the safety and efficacy of CNV1014802 in patients
with trigeminal neuralgia. [2013]
Management of painful neuropathies. [2013]
Concentration-effect relationships with perampanel in patients with
pharmacoresistant partial-onset seizures. [2013]
Retigabine for the adjunctive treatment of adults with partial-onset seizures in
epilepsy with and without secondary generalization : a NICE single technology
appraisal. [2013]
Polarity index of pharmacological agents used for maintenance treatment of
bipolar disorder. [2012]
Interventions for preventing neuropathy caused by cisplatin and related compounds. [2011.02.16]
Levetiracetam in patients with impulsive aggression: a double-blind, placebo-controlled trial. [2008.02]
Erythrocyte and plasma fatty acid profiles in patients with epilepsy: does carbamazepine affect omega-3 fatty acid concentrations? [2008.02]
Management of neuropathic pain. [2007.08]
Seizure-free outcome in randomized add-on trials of the new antiepileptic drugs. [2007.07]
How reliable is early treatment response in predicting long-term seizure outcome? [2007.06]
Seizure-Free Outcome in Randomized Add-on Trials of the New Antiepileptic Drugs. [2007.05.23]
ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. [2006.07]
[Use of antiepileptic drugs in bipolar disorder] [2006.01]
Safety, tolerability, and pharmacokinetic profile of BIA 2-093, a novel putative antiepileptic, in a rising multiple-dose study in young healthy humans. [2004.08]
Safety, tolerability and pharmacokinetic profile of BIA 2-093, a novel putative antiepileptic agent, during first administration to humans. [2003]
Other research related to Trileptal (Oxcarbazepine)
[Clinical efficacy of oxcarbazepine suspension in children with focal epilepsy]. [Article in Chinese] [2013]
Impact of oxcarbazepine sulfate metabolite on incurred sample reanalysis and quantification of oxcarbazepine. [2011.05]
Effect of lamotrigine, oxcarbazepine and topiramate on cognitive functions and oxidative stress in PTZ-kindled mice. [2011.04]
Effects of chronic treatment with valproate and oxcarbazepine on testicular development in rats. [2011.04]
Seizure after intrathecal baclofen bolus in a multiple sclerosis patient treated with oxcarbazepine. [2011.04]
Pilot association study of oxcarbazepine-induced mild cutaneous adverse reactions with HLA-B*1502 allele in Chinese Han population. [2011.03]
Pharmacological interaction between oxcarbazepine and two COX inhibitors in a rat model of inflammatory hyperalgesia. [2011.01]
Pharmacokinetics of the monohydroxy derivative of oxcarbazepine and its
enantiomers after a single intravenous dose given as racemate compared with a
single oral dose of oxcarbazepine. [2011]
Drug monitoring of lamotrigine and oxcarbazepine combination during pregnancy. [2010.12]
[Multicenter observational study of the effect of oxcarbazepine on the general well-being of adults with partial epilepsy]. [2010.11.30]
Phenytoin toxicity secondary to an oxcarbazepine-phenytoin 2C19 interaction. [2010.11]
Risk factors of oxcarbazepine-induced hyponatremia in patients with epilepsy. [2010.11]
Additive interactions of pregabalin with lamotrigine, oxcarbazepine and topiramate in the mouse maximal electroshock-induced seizure model: a type I isobolographic analysis for non-parallel dose-response relationship curves. [2010.10]
Effect of carbamazepine and oxcarbazepine on wild-type and mutant neuronal nicotinic acetylcholine receptors linked to nocturnal frontal lobe epilepsy. [2010.09.15]
Clinical feasibility of immediate overnight switching from slow-release carbamazepine to oxcarbazepine in Korean patients with refractory partial epilepsy. [2010.07]
Effects of oxcarbazepine and carbamazepine on driving ability: a double-blind, randomized crossover trial with healthy volunteers. [2010.05]
Safety profile of oxcarbazepine: results from a prescription-event monitoring study. [2010.05]
Interactions of 1-methyl-1,2,3,4-tetrahydroisoquinoline with lamotrigine, oxcarbazepine, pregabalin, and topiramate in the mouse maximal electroshock-induced seizure model: a type I isobolographic analysis. [2010.05]
Caffeine reverses antinociception by oxcarbazepine by inhibition of adenosine A1 receptors: insights using knockout mice. [2010.04.12]
The role of carbamazepine and oxcarbazepine in alcohol withdrawal syndrome. [2010.04]
Oxcarbazepine for the treatment of trichotillomania. [2010.03]
[Therapeutic drug monitoring of oxcarbazepine] [2010.01]
Effects of charcoal on the absorption and elimination of the antiepileptic drugs lamotrigine and oxcarbazepine. [2010]
Effect of eslicarbazepine acetate and oxcarbazepine on cognition and psychomotor
function in healthy volunteers. [2010]
Oxcarbazepine versus carbamazepine monotherapy for partial onset seizures. [2009.10.07]
Oxcarbazepine in combination with Tiaprid in inpatient alcohol-withdrawal--a RCT. [2009.09]
|